Abstract:Dissecting large bulk RNA-seq data into cell proportions and cell type specific expression profiles could significantly enhance our understanding of disease mechanisms at cell level and facilitate the identification of novel drug targets and development of efficient intervention strategies. In this study, we presented a scRNA-seq marker (gene) informed cell deconvolution and expression inference (CausalCellInfer) framework. CausalCellInfer employed causal inference principles to automatically identify a small set of critical marker genes from the reference scRNA-seq dataset. It then integrates deep neural networks with regularized matrix completion algorithms to deconvolute cell proportions and estimate cell type specific (CTS) expression profiles. Most importantly, we pioneered the application of the proposed framework to imputed expression data from large-scale genome-wide association studies (GWAS). We verified the efficacy of our proposed method by comparing it against existing state-of-the-art cell deconvolution methods, including CIBERSORTx, DWLS, Scaden, and MuSic across various real and pseudo-bulk samples. Furthermore, we proposed the use of a wide range of enrichment analyses to demonstrate the reliability of CausalCellInfer in estimating CTS profiles. Our proposed framework consistently outperformed existing methods with significantly higher concordance correlation coefficient (CCC), lower mean absolute error (MAE) and root mean square error (RMSE) across all testing real and pseudo bulk samples. Importantly, it also demonstrated superior computational efficiency compared to all benchmarked methods except MuSic. We also applied our trained models to deconvolute 4 tissue-specific expression cell proportions and estimate the corresponding CTS expression profiles, leveraging UK Biobank data (UKBB). We conducted a series of cellular-level analyses, including cell proportion association analysis, causal gene detection, transcriptome wide association analysis (TWAS), for 24 phenotypes in UKBB based on estimated cell composition and CTS expression profiles. Of note, the estimated proportions of various cell types were indicative of disease onset. For example, T2DM patients demonstrated a significant decrease in the proportions of alpha and beta cells in comparison to controls. We also tested their associations. Our method exhibited satisfactory positive predictive values (PPV) in uncovering differentially expressed (DE) genes for the majority of cell types. Encouragingly, most identified CTS causally relevant genes were found to be significantly enriched in target diseases or related pathophysiology. In conclusion, we presented a novel framework for inferring cell-type proportions and CTS expression, with novel applications to GWAS-imputed expression data from large-scale biobank program. Our work also shed light on how differential cell-type proportion and CTS expression may be associated with susceptibility to different diseases and their prognoses, bridging scRNA-seq and clinical phenotypes in large-scale biobank studies.

Inferring causal cell types of human diseases and risk variants from candidate regulatory elements

Revealing brain cell-stratified causality through dissecting causal variants according to their cell-type-specific effects on gene expression

Estimating cell compositions and cell-type-specific expressions from GWAS data using invariant causal prediction, deep learning and regularized matrix completion

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Genome-wide enhancer maps link risk variants to disease genes

Single cell variant to enhancer to gene map for coronary artery disease

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles

Integrative modeling of eQTLs and cis-regulatory elements suggest mechanisms underlying cell type specificity of eQTLs

A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders

Genome-wide fine-mapping improves identification of causal variants

Single-cell genomics improves the discovery of risk variants and genes of cardiac traits

Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types

Fine-mapping causal tissues and genes at disease-associated loci

A method for scoring the cell type-specific impacts of noncoding variants in personal genomes

A New Approach for Discovering Functional Links Connecting Non-Coding Regulatory Variants to Gene Targets

Micro-capture-C in vessel wall cell types identifies mechanisms underlying coronary artery disease susceptibility loci

Identifying genetic variants that influence the abundance of cell states in single-cell data

Genetic regulation of cell type–specific chromatin accessibility shapes brain disease etiology

Single-Nucleus Atlas of Cell-Type Specific Genetic Regulation in the Human Brain

An analytical method for the identification of cell type-specific disease gene modules